The lack of money for research endangers the attention to the patient.

London, 2011- June/PRNewswire /. The European Hematologists fire alarms about the lack of money for research for blood disorders. “Leukaemia kills more than 95,000 people in Europe every year;” “The EU offers few opportunities for the Hematologists to finance his research,” said Dr. Robin Foa, director-general of the European Hematology Association (EHA) at its annual Congress in London. Last Friday, June 10, the European Commission ended the process of consultation on the forthcoming EU research programme. EHA asks for help to the Commission to consider more opportunities for funding for Hematology program.

“Not only are disorders blood such as anemia, coagulation and haemophilia diseases more expanded in Europe, blood cancers kill more than 95,000 people in the EU each year. given this impact on the health of Europeans, especially the young and the elderly””, it is surprising how few resources are made available by the European Commission for haematological research,” said Foa.

The research of the Hematologists is responsible for major scientific advances in research of cancer, personalized medicine and stem cells which have found applications in many other disciplines such as Oncology, cardiology, immunotherapy or even the Rheumatology or organ transplantation. Researchers in hematology are also excellent in translational research, quickly leading the laboratory results to clinical practice. “For example, the main role of objective therapy in Oncology comes revolutionary haematological research on leukemia which changed the natural course of disease.” “I have the impression that the Commission is not aware of our excellent record to continue and enhance the leadership position that European Hematology possesses globally,” he argued, Foa.

EHA, European representative of medical specialists in the field of blood disorders, currently holds its Conference. In its response to the consultation, the EHA calls on the Commission to create more opportunities for funding in hematology in its next programme of research.

EHA is an NGO that promotes excellence in clinical practice, research and education in the European hematology. EHA represents the Hematologists of Europe (more than 3,000 members, more than 9,000 participating Hematologists in Congress, and the main publication in Europe, Haematologica/The Hematology Journal. haematology

–
fuente:

WHO (2008).) The global burden of disease.

ECO. International Agency for Research on Cancer.